BlackRock Fund Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$168M Buy
1,138,554
+132,412
+13% +$19.2M 0.03% 785
2016
Q3
$127M Buy
1,006,142
+74,697
+8% +$9.01M 0.03% 897
2016
Q2
$105M Buy
931,445
+38,161
+4% +$3.96M 0.02% 931
2016
Q1
$93M Sell
893,284
-2,582
-0.3% -$247K 0.02% 1018
2015
Q4
$101M Buy
895,866
+49,869
+6% +$5.51M 0.02% 950
2015
Q3
$92.6M Buy
845,997
+35,895
+4% +$3.84M 0.02% 969
2015
Q2
$77.5M Buy
810,102
+22,624
+3% +$2.11M 0.02% 1208
2015
Q1
$73.3M Buy
787,478
+48,204
+7% +$4.22M 0.02% 1233
2014
Q4
$60.5M Buy
739,274
+72,426
+11% +$5.55M 0.02% 1327
2014
Q3
$42.8M Sell
666,848
-22,117
-3% -$1.35M 0.01% 1455
2014
Q2
$41.9M Sell
688,965
-35,188
-5% -$2.08M 0.01% 1514
2014
Q1
$43.4M Buy
724,153
+15,455
+2% +$952K 0.01% 1510
2013
Q4
$45.2M Buy
708,698
+21,587
+3% +$1.39M 0.01% 1469
2013
Q3
$46.7M Buy
687,111
+79,048
+13% +$5.64M 0.02% 1394
2013
Q2
$43.8M Buy
+608,063
New +$40.2M 0.02% 1318

Other funds holding ICUI

BlackRock Fund Advisors's ICUI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its ICU Medical (ICUI) stake by 13% in Q4 2016, buying an estimated $19.2M and bringing the position to 1,138,554 shares worth $168M. The position accounts for 0.03% of the portfolio, ranked #785.

BlackRock Fund Advisors first reported a position in ICUI in Q2 2013 and has held it in 15 quarters since. 248 funds tracked by Wall St. Rank hold ICUI as of Q4 2016.

  • BlackRock Fund Advisors held 1,138,554 shares of ICU Medical worth $168M as of Q4 2016.
  • BlackRock Fund Advisors bought 132,412 ICU Medical shares in Q4 2016, an estimated $19.2M.
  • ICU Medical made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #785 holding.
  • BlackRock Fund Advisors first reported a position in ICU Medical in Q2 2013 and has held it in 15 quarters since.
  • 248 funds tracked by Wall St. Rank held ICU Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.